Levetiracetam Tad

Levetiracetam, the active ingredient in Levetiracetam Tad, is an antiepileptic presented as an oral tablet for oral use. It is employed to control various seizure types in patients diagnosed with epilepsy. GNH USA supplies Levetiracetam Tad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug indicated for several seizure disorders. - Partial‑onset seizures: reduces frequency and severity of focal seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: diminishes sudden muscle jerks associated with this seizure type.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: increased tiredness or lack of energy. - Somnolence: excessive sleepiness. - Irritability: mood changes or agitation. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe psychiatric reactions: depression, anxiety, or suicidal thoughts. - Stevens‑Johnson syndrome: rare skin blistering disorder. - Blood dyscrasias: anemia, leukopenia, or thrombocytopenia. - Hypersensitivity: rash, fever, or angioedema. - Rhabdomyolysis: muscle breakdown leading to renal impairment. - Hepatic injury: elevated liver enzymes or hepatitis.

When prescribing Levetiracetam, clinicians should consider several safety aspects. - Renal impairment: adjust dose in patients with reduced kidney function. - Psychiatric history: monitor for mood changes or suicidal ideation. - Discontinuation: avoid abrupt cessation to prevent seizure worsening. - Pregnancy: safety category unknown; weigh benefits against potential risks. - Elderly patients: start at lower dose and titrate cautiously. - Storage: Store at ambient temperature: keep below 25°C, retain in original container, protect from moisture.

Levetiracetam can interact with other medicines that affect its plasma levels.

Major Interactions (Avoid): - Carbamazepine: enzyme induction may lower levetiracetam concentrations. - Phenytoin: may reduce levetiracetam efficacy through increased metabolism. - Phenobarbital: can decrease levetiracetam levels, risking seizure control.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam exposure, requiring dose review. - Other antiepileptics (e.g., lamotrigine): monitor for additive side effects. - Oral contraceptives: levetiracetam may reduce hormonal efficacy, advise alternative contraception.